← Browse by Condition
Medical Condition

pleural mesotheliomas

Total Trials
1
Recruiting Now
1
Trial Phases
Phase 2
NCT06840834 Phase 2
Recruiting

Evaluating Ivonescimab as a Potential Treatment for Pleural Mesothelioma Patients Whose Cancer Has Returned After Previous Immunotherapy and Chemotherapy

Enrollment
38 pts
Location
France
Sponsor
Intergroupe Francophone de Can...
View Trial →